Standard Chemotherapy Followed by Capecitabine as Prolonged Postoperative Adjuvant Treatment for Breast Cancer
NCT02842099
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
TA or TAC
DRUG:
X
Sponsor
Peking Union Medical College Hospital